321 related articles for article (PubMed ID: 12143040)
1. Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver.
Zhao P; Kalhorn TF; Slattery JT
Hepatology; 2002 Aug; 36(2):326-35. PubMed ID: 12143040
[TBL] [Abstract][Full Text] [Related]
2. Effects of ethanol dose and ethanol withdrawal on rat liver mitochondrial glutathione: implication of potentiated acetaminophen toxicity in alcoholics.
Zhao P; Slattery JT
Drug Metab Dispos; 2002 Dec; 30(12):1413-7. PubMed ID: 12433812
[TBL] [Abstract][Full Text] [Related]
3. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.
Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215
[TBL] [Abstract][Full Text] [Related]
4. Role of medium-chain triglycerides in the alcohol-mediated cytochrome P450 2E1 induction of mitochondria.
Lieber CS; Cao Q; DeCarli LM; Leo MA; Mak KM; Ponomarenko A; Ren C; Wang X
Alcohol Clin Exp Res; 2007 Oct; 31(10):1660-8. PubMed ID: 17681033
[TBL] [Abstract][Full Text] [Related]
5. Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice.
Wolf KK; Wood SG; Allard JL; Hunt JA; Gorman N; Walton-Strong BW; Szakacs JG; Duan SX; Hao Q; Court MH; von Moltke LL; Greenblatt DJ; Kostrubsky V; Jeffery EH; Wrighton SA; Gonzalez FJ; Sinclair PR; Sinclair JF
Drug Metab Dispos; 2007 Jul; 35(7):1223-31. PubMed ID: 17392391
[TBL] [Abstract][Full Text] [Related]
6. Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity.
Kostrubsky VE; Szakacs JG; Jeffery EH; Wood SG; Bement WJ; Wrighton SA; Sinclair PR; Sinclair JF
Toxicol Appl Pharmacol; 1997 Apr; 143(2):315-23. PubMed ID: 9144448
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity of acetaminophen and N-acetyl-p-benzoquinone imine and enhancement by fructose.
Hojo M; Hanioka K; Miyata M; Yamazoe Y
Xenobiotica; 2000 Sep; 30(9):933-41. PubMed ID: 11055270
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice.
Tonge RP; Kelly EJ; Bruschi SA; Kalhorn T; Eaton DL; Nebert DW; Nelson SD
Toxicol Appl Pharmacol; 1998 Nov; 153(1):102-8. PubMed ID: 9875304
[TBL] [Abstract][Full Text] [Related]
9. Double null of selenium-glutathione peroxidase-1 and copper, zinc-superoxide dismutase enhances resistance of mouse primary hepatocytes to acetaminophen toxicity.
Zhu JH; Lei XG
Exp Biol Med (Maywood); 2006 May; 231(5):545-52. PubMed ID: 16636302
[TBL] [Abstract][Full Text] [Related]
10. Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in Cyp2e1(-/-) mice.
Sinclair JF; Szakacs JG; Wood SG; Walton HS; Bement JL; Gonzalez FJ; Jeffery EH; Wrighton SA; Bement WJ; Sinclair PR
Toxicol Appl Pharmacol; 2000 Oct; 168(2):114-22. PubMed ID: 11032766
[TBL] [Abstract][Full Text] [Related]
11. A 1H NMR-based metabolomics approach for mechanistic insight into acetaminophen-induced hepatotoxicity.
Fukuhara K; Ohno A; Ando Y; Yamoto T; Okuda H
Drug Metab Pharmacokinet; 2011; 26(4):399-406. PubMed ID: 21670543
[TBL] [Abstract][Full Text] [Related]
12. Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.
Moffit JS; Aleksunes LM; Kardas MJ; Slitt AL; Klaassen CD; Manautou JE
Toxicology; 2007 Feb; 230(2-3):197-206. PubMed ID: 17188792
[TBL] [Abstract][Full Text] [Related]
13. Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women.
Mian P; van den Anker JN; van Calsteren K; Annaert P; Tibboel D; Pfister M; Allegaert K; Dallmann A
Clin Pharmacokinet; 2020 Jan; 59(1):97-110. PubMed ID: 31347013
[TBL] [Abstract][Full Text] [Related]
14. Prevention of acetaminophen (APAP)-induced hepatotoxicity by leflunomide via inhibition of APAP biotransformation to N-acetyl-p-benzoquinone imine.
Tan SC; New LS; Chan EC
Toxicol Lett; 2008 Aug; 180(3):174-81. PubMed ID: 18588957
[TBL] [Abstract][Full Text] [Related]
15. Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration.
Jiang Y; Fan X; Wang Y; Chen P; Zeng H; Tan H; Gonzalez FJ; Huang M; Bi H
Toxicol Sci; 2015 Jan; 143(1):107-15. PubMed ID: 25319358
[TBL] [Abstract][Full Text] [Related]
16. Acetaminophen reactive intermediates target hepatic thioredoxin reductase.
Jan YH; Heck DE; Dragomir AC; Gardner CR; Laskin DL; Laskin JD
Chem Res Toxicol; 2014 May; 27(5):882-94. PubMed ID: 24661219
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice.
Lin MC; Wang EJ; Patten C; Lee MJ; Xiao F; Reuhl KR; Yang CS
J Biochem Toxicol; 1996; 11(1):11-20. PubMed ID: 8806047
[TBL] [Abstract][Full Text] [Related]
18. Isatidis Folium alleviates acetaminophen-induced liver injury in mice by enhancing the endogenous antioxidant system.
Ding CH; Zhu H
Environ Toxicol; 2020 Nov; 35(11):1251-1259. PubMed ID: 32677766
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine amide, a promising antidote for acetaminophen toxicity.
Khayyat A; Tobwala S; Hart M; Ercal N
Toxicol Lett; 2016 Jan; 241():133-42. PubMed ID: 26602168
[TBL] [Abstract][Full Text] [Related]
20. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury.
Shayiq RM; Roberts DW; Rothstein K; Snawder JE; Benson W; Ma X; Black M
Hepatology; 1999 Feb; 29(2):451-63. PubMed ID: 9918922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
